Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/1996
11/19/1996US5576000 Envelope protein of hiv with sequences
11/19/1996CA2096315C Human rotaviruses, vaccines and methods
11/14/1996WO1996035798A1 Improved retroviral vectors, especially suitable for gene therapy
11/14/1996WO1996035454A1 Stable virus packaging cell lines
11/14/1996CA2218808A1 Improved retroviral vectors, especially suitable for gene therapy
11/13/1996EP0741793A1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof
11/13/1996EP0741516A1 Ancient organisms
11/13/1996EP0589877B1 METHODS FOR PRODUCING FUNCTIONAL, SINGLE-CHAIN Fv ANTIBODY FRAGMENTS ON THE SURFACE OF BACTERIOPHAGE PARTICLES
11/13/1996EP0496787B1 Novel infectious bursal disease virus
11/13/1996EP0474868B1 Method of producing core structure of retro virus and particle produced thereby
11/07/1996WO1996034942A1 Novel retrovirus and diagnostic methods
11/07/1996WO1996034625A1 Recombinant vesiculoviruses and their uses
11/07/1996CA2231854A1 Novel retrovirus and diagnostic methods
11/06/1996CN1135237A Products that elicit neutralizing antibodies against genetically divergent HIV-1 strains
11/06/1996CN1134982A Gene of Chinese strain herpes simplex virus thymidine kinase, and application of same
11/06/1996CN1033215C Process for prepn. of biologic medicine for anti tumour
11/05/1996US5571712 Non-infectious, replication defective, immunogenic HIV retrovirus-like particles produced from a recombinant HIV genome devoid of long terminal repeats
11/05/1996US5571709 Modified baculovirus and baculovirus expression vectors
11/05/1996US5571698 Genetic package, chimeric
10/1996
10/31/1996WO1996013597A3 Improved adenovirus and methods of use thereof
10/30/1996EP0739414A1 Herpesvirus replication defective mutants
10/30/1996EP0739413A1 Method of selecting specific bacteriophages
10/24/1996WO1996033280A1 An adenovirus helper-virus system
10/24/1996CA2218610A1 An adenovirus helper-virus system
10/23/1996EP0738327A1 Host-vector system for use in gene therapy
10/23/1996EP0738319A1 Purification of retroviral vectors
10/23/1996EP0431072B1 Recombinant fowlpox virus
10/23/1996EP0427767B1 Vaccine
10/23/1996CN1134175A Viral vector with bovine viral diarrhea virus (BVDV) antigens
10/23/1996CN1134174A Modified plant viruses as vectors of heterologous peptides
10/22/1996US5567603 HIV-3 retrovirus and its use
10/17/1996WO1996032489A1 Glucose-inducible recombinant viral vector
10/17/1996WO1996021020A3 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
10/17/1996CA2215987A1 Glucose-inducible recombinant viral vector
10/16/1996EP0737248A1 Gene expression control
10/16/1996EP0737247A1 Method and reagent for inhibiting hepatitis c virus replication
10/16/1996EP0737085A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS)
10/16/1996EP0601062B1 Sirs vaccine and diagnosis method
10/15/1996US5565549 Retroviruse, aids
10/15/1996US5565319 Enzyme-linked immunosorbent assay comprising solid phase coated with viral antigen to which antibodies in sample will bind, detectable label conjugate which will bind to antibodies
10/15/1996US5565203 Hepatitis A virus in a reconstituted influenza virosome and use as a vaccine
10/10/1996WO1996031602A1 Retroviral vectors
10/09/1996EP0736100A1 Recombinant protein production in bovine adenovirus expression vector system
10/09/1996EP0736089A1 Thermostable varicella zoster virus
10/09/1996CN1133013A Vaccin respiratory syncytial viral vaccines
10/03/1996WO1996030535A1 Gene transfer into the kidney
10/03/1996WO1996030533A1 Pseudotyped retroviral particles
10/03/1996WO1996030523A2 Antigen presentation system based on retrovirus-like particles
10/03/1996WO1996030514A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/03/1996WO1996030499A1 Cell line and process for multiplying rabies viruses and their quantitative detection
10/03/1996WO1996030387A1 Novel human cytomegalovirus dna sequences
10/03/1996WO1996030385A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
10/03/1996CA2216878A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
10/03/1996CA2214499A1 Gene transfer into the kidney
10/02/1996EP0734448A1 Gene therapy for restenosis using an adenoviral vector
10/02/1996EP0734447A1 Animal model of the alzheimer disease, preparation and utilisations
10/02/1996EP0471794B1 Antiviral therapy using thiazine and xanthene dyes
10/02/1996DE19512057A1 Zellinie und Verfahren zur Vermehrung von Tollwutviren und deren quantitativen Nachweis Cell line and method for propagating rabies viruses and their quantitative detection
10/02/1996CN1132249A Process for inactivation of viruses with aid of acridine or acridine derivatives
10/02/1996CN1132247A Establishment and application of GP125 gene engineering strain containing EB virus shell albumen
10/01/1996US5561063 Recombinant human cytomegalovirus containing foreign gene
09/1996
09/26/1996WO1996029413A2 Dna encoding human papilloma virus type 18
09/26/1996WO1996029396A1 Recombinant infectious laryngotracheitis virus and uses thereof
09/26/1996WO1996029096A1 Gene transfer preparation
09/26/1996WO1996021014A3 Production and administration of high titer recombinant retroviruses
09/26/1996WO1996011272A3 Papilloma virus-like particles, fusion proteins and process for producing the same
09/26/1996CA2216139A1 Recombinant infectious laryngotracheitis virus and uses thereof
09/25/1996EP0733103A1 Generation of high titers of recombinant aav vectors
09/25/1996EP0733068A1 METHODS AND COMPOSITIONS FOR THE SUPPRESSION OF $i(NEU) MEDIATED TRANSFORMATION
09/25/1996EP0587805B1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1
09/24/1996US5559250 Treating red blood cell solutions with anti-viral agents
09/24/1996US5559099 Penton base protein and methods of using same
09/19/1996WO1996028564A1 Novel recombinant dna vectors for gene therapy
09/19/1996WO1996028563A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
09/19/1996WO1996028553A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy
09/19/1996WO1996028552A1 Rheumatoid arthritis-related virus msrv-1 and pathogenic and/or infective agent msrv-2
09/19/1996CA2214010A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy
09/18/1996EP0732405A1 Recombinant DNA virus and method for preparation thereof
09/18/1996EP0732104A1 Useful composition for the manufacture of vaccines containing particles bearing a hepatitis B virus surface antigen and polymerized human seric albumin receptor, animal cells able to produce such particles and process for their obtention
09/18/1996EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
09/18/1996EP0731838A1 Binding structures directed against the ca55.1 antigen
09/16/1996CA2171368A1 Recombinant dna virus and method for preparation thereof
09/12/1996WO1996027677A2 Method of purification of recombinant viral vectors containing a therapeutic gene
09/12/1996WO1996027603A1 Compositions and methods for the treatment and diagnosis of immune disorders
09/12/1996WO1996027292A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
09/12/1996CA2214723A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
09/12/1996CA2214589A1 Compositions and methods for the treatment and diagnosis of immune disorders
09/11/1996EP0731168A1 MSRV-1 virus and pathogenic and/or infectious agent MSRV-2 associated with rheumatoid arthritis
09/11/1996EP0731165A2 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160
09/11/1996EP0528903B1 Methods of preventing viral replication
09/11/1996CN1032762C Method of producing peptides
09/10/1996US5554538 DNA sequences derived from papillomavirus HPV-33 genome
09/10/1996US5554524 More complex type retroviruses having mixed type LTR, and uses thereof
09/10/1996CA2171242A1 Msrv-1 virus and pathogenic and/or infective msrv-2 related to rhumatoid arthritis
09/08/1996CA2171144A1 Human t-cell line infected with hiv-2 which secretes functionally intact hiv-2 gp160
09/06/1996WO1996027013A1 Group o hiv-1, fragments of such viruses, and uses thereof
09/06/1996WO1996026742A1 Gene transfer-mediated angiogenesis therapy
09/06/1996WO1996021035A3 Retroviral delivery of full length factor VIII
09/06/1996WO1996021007A3 Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells
09/06/1996CA2188575A1 Gene transfer-mediated angiogenesis therapy
1 ... 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 ... 267